Vote in the European Parliament

2022 discharge: General budget of the EU - European Public Prosecutors Office (the ‘EPPO’)

Date: 11.04.2024·Reference: A9-0117/2024
Rapporteur: Luke Ming Flanagan

Overall Result

Adopted
  • 487 For
  • 87 Against
  • 18 Abstention
  • 113 Did not vote
Status and procedure

Outcome as recorded by the European Parliament.

Vote held on
Latest recorded step
Official Journal · (764 days ago)
Next scheduled step
No further step is scheduled in the source.
Publication in the Official Journal recorded

Procedure timeline

2023/2139(DEC) · DEC

Recorded procedure activities. These do not establish whether a law has entered into force.

  1. Recorded: Referral29 days until the next step
  2. Recorded: Committee stage154 days until the next step
  3. Recorded: Plenary29 days until the next step
  4. Recorded: Other activity182 days until the next step
  5. Latest recorded: Official Journal
Recorded activities (13)
  1. Referral to committee
  2. Committee opinion tabled
  3. Committee opinion tabled
  4. Committee opinion adopted
  5. Committee report tabled
  6. Committee opinion adopted
  7. Committee report adopted
  8. Tabling for plenary
  9. Plenary debate
  10. Other recorded activity
  11. Plenary vote
  12. Plenary vote results
  13. Publication in the Official Journal
Scheduled activities (not confirmation of completion)
  1. Plenary debate
  2. Plenary vote

Procedure file (OEIL) · European Parliament data
Retrieved:

Sources

Data: EP Open Data API

Amendment history (2)

Wording as published by the EP, in English.

  1. Amendment 1 · Motion for a resolutionRejected

    Recital K a (new)

    Tabled by Cristian Terheş, Ryszard Czarnecki · ECR

    Added: K a. Whereas on 14 October 2022, the European Public Prosecutor’s Office announced that there is an ongoing investigation into the acquisition of COVID-19 vaccines in the Union and the fact that this exceptional confirmation comes after the extremely high public interest on the matter1a; 1a https://www.eppo.europa.eu/en/news/ongoing-eppo-investigation-acquisition-covid-19-vaccines-eu

  2. Amendment 2 · Motion for a resolutionRejected

    Paragraph 29 a (new)

    Tabled by Cristian Terheş, Ryszard Czarnecki · ECR

    Added: 29 a. Highlights the critical necessity of promptly dedicating necessary resources to ensure the timely conclusion of the ongoing investigation into the acquisition of the COVID-19 vaccine in the Union, especially considering the substantial public interest in this matter, coupled with the fact that the investigation already commenced in 2022 and to this date no decision has been publicly announced;

Vote by political group

How the political groups voted

Members

Showing 10 of 705

Vote Position
NameCountryGroupVote Position
GermanyNI
For
GermanyS&D
For
FinlandRenew
For
RomaniaS&D
For
PortugalS&D
For
CzechiaRenew
For
LithuaniaEPP
For
SpainS&D
For
GermanyS&D
For
BelgiumPfE
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en